| Prev Close | 30.81 |
| Day Low/High | 29.26 / 30.98 |
| 52 Wk Low/High | 23.07 / 67.74 |
BioXcel Therapeutics, Inc. (BTAI)
29.38
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 27.97B |
| Market Cap | 861.72M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
You've Got Volatility 'Covered' With This Strategy
This simple option strategy, which I continue to use with small-cap biotechs, is one of the easiest and cheapest risk mitigation approaches an individual can take.
I See Covered Call Opportunities in These 2 Biotechs
I continue to put new money to work in BioXcel Therapeutics and GoHealth.
An All-Terrain Strategy for Portfolio Management
The market's mood seems to be changing almost daily; he's an approach for how to trade it regardless of how it's feeling on any particular day.
One Man's Plan for Navigating the Choppy Rising Rate Seas
Putting cash to work on significant market pullbacks such as the one that occurred Thursday is a key element of the strategy.
2 Potential Acquisition Targets as Biotech Deal Activity Picks Up
BioXcel Therapeutics and Avadel Pharmaceuticals would make good additions to the portfolios of larger drug companies.
Biotech M&A Picks Up: Lessons for Investors and Potential Targets
The euphoria in biotech stocks Monday was a nice change of pace. It also brought to the forefront some lessons about M&A in this industry.
This Is Great Action for Stock Pickers Right Now
Stick to themes like biotechnology, SPACs, EV batteries, and others.
2 Small Biotechs That Have Attracted My Attention and My Cash
BioXcel Therapeutics and Avadel Pharmaceuticals are new additions to my personal portfolio based on their promising drug prospects.
Stubborn Market Refuses to Budge From Uptrend
Most notable is how the coronavirus issue is having no negative impact.